<b>Characterization of seven novel mutations in seven patients with GAMT deficiency</b>
Chike Bellarmine Item(Medical University of Vienna), Sylvia Stöckler‐Ipsiroglu(Vienna General Hospital), Marta Vilaseca(Hospital Sant Joan de Déu Barcelona), H Korall(Reutlingen University), Saadet Mercimek‐Mahmutoglu(University of Toronto), Roberta Battini(Fondazione Stella Maris), C. Edlinger-Horvat(Vienna General Hospital), Adolf Mühl(Medical University of Vienna), Olaf A. Bodamer(Broad Institute), Carmen Stromberger(Berlin Institute of Health at Charité - Universitätsmedizin Berlin)
Cited by 51
Related Papers
Patient-Customized Oligonucleotide Therapy for a Rare Genetic Disease
|New England Journal of Medicine|2019|823
Characterization of human disease phenotypes associated with mutations in <i>TREX1</i>, <i>RNASEH2A</i>, <i>RNASEH2B</i>, <i>RNASEH2C</i>, <i>SAMHD1</i>, <i>ADAR</i>, and <i>IFIH1</i>
|American Journal of Medical Genetics Part A|2015|617
Mucopolysaccharidosis type II (Hunter syndrome): a clinical review and recommendations for treatment in the era of enzyme replacement therapy
|European Journal of Pediatrics|2007|535
Whole-genome sequencing expands diagnostic utility and improves clinical management in paediatric medicine
|npj Genomic Medicine|2016|377
Mutations in SLC39A14 disrupt manganese homeostasis and cause childhood-onset parkinsonism–dystonia
|Nature Communications|2016|326